Journey Medical Corp. (DERM)
7.91
+0.16
(+2.06%)
USD |
NASDAQ |
Aug 24, 16:00
7.75
-0.16
(-2.02%)
After-Hours: 07:48
Journey Medical EPS Diluted (Quarterly) : -0.0114 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0114 |
| March 31, 2026 | -0.0817 |
| December 31, 2025 | -0.0459 |
| September 30, 2025 | -0.0928 |
| June 30, 2025 | -0.163 |
| March 31, 2025 | -0.1801 |
| December 31, 2024 | 0.0687 |
| September 30, 2024 | -0.1164 |
| June 30, 2024 | -0.1681 |
| March 31, 2024 | -0.5285 |
| December 31, 2023 | -0.1109 |
| September 30, 2023 | 0.7982 |
| June 30, 2023 | -0.4645 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.5692 |
| December 31, 2022 | -0.6002 |
| September 30, 2022 | -0.5721 |
| June 30, 2022 | -0.4313 |
| March 31, 2022 | -0.0796 |
| December 31, 2021 | -1.256 |
| September 30, 2021 | -0.639 |
| June 30, 2021 | -0.7122 |
| March 31, 2021 | 0.0161 |
| December 31, 2020 | 0.1502 |
| September 30, 2020 | 0.0017 |
| June 30, 2020 | 0.0273 |
| March 31, 2020 | 0.1379 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nektar Therapeutics | -1.229 |
| ANI Pharmaceuticals, Inc. | 1.052 |
| Corcept Therapeutics, Inc. | 0.356 |
| Veru, Inc. | -0.3032 |
| Johnson & Johnson | 2.268 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.312M |
| Revenue (Quarterly) | 18.51M |
| Total Expenses (Quarterly) | 18.82M |
| Enterprise Value | 218.67M |
| Gross Profit Margin (Quarterly) | 61.58% |
| Profit Margin (Quarterly) | -1.69% |
| Earnings Yield | -2.93% |
| Normalized Earnings Yield | -2.929 |